Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer

Journal of Human Nutrition and Dietetics

Volumn 28, Issue 3, 2015, Pages 272-282

  Crew, K D ^a   Ho, K A ^a   Brown, P ^b   Greenlee, H ^a   Bevers, T B ^b   Arun, B ^b   Sneige, N ^b   Hudis, C ^c   Mcarthur, H L ^c   Chang, J ^d   Rimawi, M ^e   Cornelison, T L ^f   Cardelli, J ^g   Santella, R M ^a   Wang, A ^a   Lippman, S M ^h   Hershman, D L ^a  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d HOUSTON METHODIST HOSPITAL   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^h UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Breast cancer; Chemoprevention; Tea polyphenols

Indexed keywords

BIOLOGICAL MARKER; CATECHIN; CHOLESTEROL; PLACEBO; PLANT EXTRACT; POLYPHENON E; SCATTER FACTOR; SIGNAL PEPTIDE; TEA; TRIACYLGLYCEROL; VASCULOTROPIN A;

ADULT; AGED; ANALOGS AND DERIVATIVES; BLOOD; BREAST TUMOR; CHEMISTRY; CONTROLLED STUDY; DRUG EFFECTS; FEMALE; HUMAN; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SIGNAL TRANSDUCTION; TEA;

ADULT; AGED; BIOMARKERS; BREAST NEOPLASMS; CATECHIN; CHOLESTEROL; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; PLACEBOS; PLANT EXTRACTS; RISK FACTORS; SIGNAL TRANSDUCTION; TEA; TRIGLYCERIDES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84929265637     PISSN: 09523871     EISSN: 1365277X     Source Type: Journal    
DOI: 10.1111/jhn.12229     Document Type: Article

References (31)

1. Bigelow, R.L. & Cardelli, J.A. (2006) The green tea catechins, (-)-epigallocatechin-3-gallate (EGCG) and (-)-epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells. Oncogene 25, 1922-1930.
2. Birchmeier, C., Birchmeier, W., Gherardi, E. & Vande Woude, G.F. (2003) Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 4, 915-925.
3. Campbell, J.S., Cardelli, J.A., McLarty, J., Hershman, D.L., Taback, B., Refice, S.F., Wang, S., Bigelow, R. & Crew, K.D. (2010) Effects of Presurgical Administration of An Oral Green Tea Extract in Women with Operable Breast Cancer. Philadelphia, PA: American Association for Cancer Research, Frontiers in Cancer Prevention.
4. Chang, P.Y., Mirsalis, J., Riccio, E.S., Bakke, J.P., Lee, P.S., Shimon, J., Phillips, S., Fairchild, D., Hara, Y. & Crowell, J.A. (2003) Genotoxicity and toxicity of the potential cancer-preventive agent Polyphenon E. Environ. Mol. Mutagen. 41, 43-54.
5. Cheung, Y.K. & Chappell, R. (2000) Sequential designs for phase I clinical trials with late-onset toxicities. Biometrics 56, 1177-1182.
6. Crew, K.D., Brown, P., Greenlee, H., Bevers, T.B., Arun, B., Hudis, C., McArthur, H.L., Chang, J., Rimawi, M., Vornik, L., Cornelison, T.L., Wang, A., Hibshoosh, H., Ahmed, A., Terry, M.B., Santella, R.M., Lippman, S.M. & Hershman, D.L. (2012) Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of Polyphenon E in women with hormone receptor-negative breast cancer. Cancer Prev. Res. (Phila) 5, 1144-1154.
7. Hakim, I.A., Harris, R.B., Brown, S., Chow, H.H., Wiseman, S., Agarwal, S. & Talbot, W. (2003) Effect of increased tea consumption on oxidative DNA damage among smokers: a randomized controlled study. J. Nutr. 133, 3303S-3309S.
8. Hsu, S.P., Wu, M.S., Yang, C.C., Huang, K.C., Liou, S.Y., Hsu, S.M. & Chien, C.T. (2007) Chronic green tea extract supplementation reduces hemodialysis-enhanced production of hydrogen peroxide and hypochlorous acid, atherosclerotic factors, and proinflammatory cytokines. Am. J. Clin. Nutr. 86, 1539-1547.
9. Inoue-Choi, M., Yuan, J.M., Yang, C.S., Van den Berg, D.J., Lee, M.J., Gao, Y.T. & Yu, M.C. (2010) Genetic association between the COMT genotype and urinary levels of tea polyphenols and their metabolites among daily green tea drinkers. Int. J. Mol. Epidemiol. Genet. 1, 114-123.
10. Liao, J., Yang, G.Y., Park, E.S., Meng, X., Sun, Y., Jia, D., Seril, D.N. & Yang, C.S. (2004) Inhibition of lung carcinogenesis and effects on angiogenesis and apoptosis in A/J mice by oral administration of green tea. Nutr. Cancer 48, 44-53.
11. Malone, K.E., Begg, C.B., Haile, R.W., Borg, A., Concannon, P., Tellhed, L., Xue, S., Teraoka, S., Bernstein, L., Capanu, M., Reiner, A.S., Riedel, E.R., Thomas, D.C., Mellemkjaer, L., Lynch, C.F., Boice, J.D. Jr, Anton-Culver, H. & Bernstein, J.L. (2010) Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. J. Clin. Oncol. 28, 2404-2410.
12. Masuda, M., Suzui, M., Lim, J.T., Deguchi, A., Soh, J.W. & Weinstein, I.B. (2002) Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. J. Exp. Ther. Oncol. 2, 350-359.
13. McLarty, J., Bigelow, R.L., Smith, M., Elmajian, D., Ankem, M. & Cardelli, J.A. (2009) Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro. Cancer Prev. Res. (Phila) 2, 673-682.
14. Moon, H.S., Lee, H.G., Choi, Y.J., Kim, T.G. & Cho, C.S. (2007) Proposed mechanisms of (-)-epigallocatechin-3-gallate for anti-obesity. Chem. Biol. Interact. 167, 85-98.
15. Murphey, L.J., Williams, M.K., Sanchez, S.C., Byrne, L.M., Csiki, I., Oates, J.A., Johnson, D.H. & Morrow, J.D. (2004) Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer. Anal. Biochem. 334, 266-275.
16. Nguyen, M.M., Ahmann, F.R., Nagle, R.B., Hsu, C.H., Tangrea, J.A., Parnes, H.L., Sokoloff, M.H., Gretzer, M.B. & Chow, H.H. (2012) Randomized, double-blind, placebo-controlled trial of Polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities. Cancer Prev. Res. (Phila) 5, 290-298.
17. Ogunleye, A.A., Xue, F. & Michels, K.B. (2010) Green tea consumption and breast cancer risk or recurrence: a meta-analysis. Breast Cancer Res. Treat. 119, 477-484.
18. Raghav, K.P., Wang, W., Liu, S., Chavez-MacGregor, M., Meng, X., Hortobagyi, G.N., Mills, G.B., Meric-Bernstam, F., Blumenschein, G.R. Jr & Gonzalez-Angulo, A.M. (2012) cMET and phospho-cMET protein levels in breast cancers and survival outcomes. Clin. Cancer Res. 18, 2269-2277.
19. Rodriguez, S.K., Guo, W., Liu, L., Band, M.A., Paulson, E.K. & Meydani, M. (2006) Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex. Int. J. Cancer 118, 1635-1644.
20. Rossner, P. Jr, Gammon, M.D., Terry, M.B., Agrawal, M., Zhang, F.F., Teitelbaum, S.L., Eng, S.M., Gaudet, M.M., Neugut, A.I. & Santella, R.M. (2006) Relationship between urinary 15-F2t-isoprostane and 8-oxodeoxyguanosine levels and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 15, 639-644.
21. Sartippour, M.R., Shao, Z.M., Heber, D., Beatty, P., Zhang, L., Liu, C., Ellis, L., Liu, W., Go, V.L. & Brooks, M.N. (2002) Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells. J. Nutr. 132, 2307-2311.
22. Seely, D., Mills, E.J., Wu, P., Verma, S. & Guyatt, G.H. (2005) The effects of green tea consumption on incidence of breast cancer and recurrence of breast cancer: a systematic review and meta-analysis. Integr. Cancer Ther. 4, 144-155.
23. Senthil Kumaran, V., Arulmathi, K., Srividhya, R. & Kalaiselvi, P. (2008) Repletion of antioxidant status by EGCG and retardation of oxidative damage induced macromolecular anomalies in aged rats. Exp. Gerontol. 43, 176-183.
24. Stearns, V., Gallagher, A., Kleer, C.G., Singh, B., Freedman, M., Haddad, B.R., Isaacs, C., Warren, R., Brown, M., Cullen, J., Trock, B. & Hayes, D.F. (2004) A pilot study to establish a clinical model to perform phase II studies of breast cancer chemopreventive agents in women at high risk with biomarkers as surrogate endpoints for activity. Clin. Cancer Res. 10, 8332-8340.
25. Stendell-Hollis, N.R., Thomson, C.A., Thompson, P.A., Bea, J.W., Cussler, E.C. & Hakim, I.A. (2010) Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors. J. Hum. Nutr. Diet. 23, 590-600.
26. Sun, C.L., Yuan, J.M., Koh, W.P. & Yu, M.C. (2006) Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies. Carcinogenesis 27, 1310-1315.
27. Swain, S.M., Wilson, J.W., Mamounas, E.P., Bryant, J., Wickerham, D.L., Fisher, B., Paik, S. & Wolmark, N. (2004) Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer. J. Natl Cancer Inst. 96, 516-523.
28. Winterbourn, C.C. & Buss, I.H. (1999) Protein carbonyl measurement by enzyme-linked immunosorbent assay. Methods Enzymol. 300, 106-111.
29. Wu, A.H., Spicer, D., Stanczyk, F.Z., Tseng, C.C., Yang, C.S. & Pike, M.C. (2012) Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy postmenopausal women. Cancer Prev. Res. (Phila) 5, 393-402.
30. Yang, C.S., Wang, X., Lu, G. & Picinich, S.C. (2009) Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat. Rev. Cancer 9, 429-439.
31. Zhu, B.H., Zhan, W.H., Li, Z.R., Wang, Z., He, Y.L., Peng, J.S., Cai, S.R., Ma, J.P. & Zhang, C.H. (2007) (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis. World J. Gastroenterol. 13, 1162-1169.